Literature DB >> 9017947

Trefoil peptides in the defense of the gastrointestinal tract.

A G Plaut1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9017947     DOI： 10.1056/NEJM199702133360712

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.

Authors:  R S Rosenberg Zand; D J Jenkins; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.

Authors:  Ju Yup Lee; Kyung Sik Park; Hyun-Gyo Lee; Won-Ki Baek; Kwang Bum Cho; Yoo Jin Lee; Yoon Suk Lee; Seung-Wan Ryu
Journal:  Clin Exp Med       Date:  2016-05-06       Impact factor: 3.984

3.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.

Authors:  Susumu Aikou; Yasukazu Ohmoto; Toshiaki Gunji; Nobuyuki Matsuhashi; Hiroshi Ohtsu; Hirona Miura; Kensuke Kubota; Yukinori Yamagata; Yasuyuki Seto; Atsushi Nakajima; James R Goldenring; Michio Kaminishi; Sachiyo Nomura
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

4.  Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.

Authors:  Yoshiki Taniguchi; Yukinori Kurokawa; Tsuyoshi Takahashi; Jota Mikami; Yasuhiro Miyazaki; Koji Tanaka; Tomoki Makino; Makoto Yamasaki; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

Review 5.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

6.  Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system.

Authors:  Anna Vossenkämper; Thomas T Macdonald; Olivier Marchès
Journal:  J Inflamm (Lond)       Date:  2011-05-03       Impact factor: 4.981

Review 7.  Diagnosis and management of high risk group for gastric cancer.

Authors:  Hyuk Yoon; Nayoung Kim
Journal:  Gut Liver       Date:  2015-01       Impact factor: 4.519

8.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.

Authors:  Yuko Ishibashi; Hiroshi Ohtsu; Masako Ikemura; Yasuko Kikuchi; Takayoshi Niwa; Kotoe Nishioka; Yoshihiro Uchida; Hirona Miura; Susumu Aikou; Toshiaki Gunji; Nobuyuki Matsuhashi; Yasukazu Ohmoto; Takeshi Sasaki; Yasuyuki Seto; Toshihisa Ogawa; Keiichiro Tada; Sachiyo Nomura
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

9.  Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.

Authors:  Toshio Yamanari; Hitoshi Sugiyama; Keiko Tanaka; Hiroshi Morinaga; Masashi Kitagawa; Akifumi Onishi; Ayu Ogawa-Akiyama; Yuzuki Kano; Koki Mise; Yasukazu Ohmoto; Kenichi Shikata; Jun Wada
Journal:  Biomed Res Int       Date:  2018-04-03       Impact factor: 3.411

10.  Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen.

Authors:  Hyun Seok Lee; Seong Woo Jeon; Sachiyo Nomura; Yasuyuki Seto; Yong Hwan Kwon; Su Youn Nam; Yuko Ishibashi; Hiroshi Ohtsu; Yasukazu Ohmoto; Hae Min Yang
Journal:  Gastroenterol Res Pract       Date:  2018-05-09       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.